Neurocognitive function after cardiac surgery: from phenotypes to mechanisms
For half a century, we have known that some patients experience neurocognitive dysfunction
after cardiac surgery, yet defining its incidence, course, and causes remains challenging …
after cardiac surgery, yet defining its incidence, course, and causes remains challenging …
[HTML][HTML] Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients
H Eggebrecht, A Schmermund… - Database of Abstracts …, 2012 - ncbi.nlm.nih.gov
This review found that transcatheter aortic valve implantation was associated with a stroke
rate of 3.3% and a mortality rate of 8.1% in the first 30 days following surgery. While this …
rate of 3.3% and a mortality rate of 8.1% in the first 30 days following surgery. While this …
Protection against cerebral embolism during transcatheter aortic valve replacement
Background: Neurological complications after transcatheter aortic valve replacement (TAVR)
may be reduced with transcatheter cerebral embolic protection (TCEP). Objectives: This …
may be reduced with transcatheter cerebral embolic protection (TCEP). Objectives: This …
Effect of a cerebral protection device on brain lesions following transcatheter aortic valve implantation in patients with severe aortic stenosis: the CLEAN-TAVI …
Importance Stroke remains a major predictor of mortality after transcatheter aortic valve
implantation (TAVI). Cerebral protection devices might reduce brain injury as determined by …
implantation (TAVI). Cerebral protection devices might reduce brain injury as determined by …
A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III …
Aims To evaluate the safety, efficacy, and performance of the TriGuard™ HDH Embolic
Deflection Device (TriGuard) compared with no cerebral protection in patients undergoing …
Deflection Device (TriGuard) compared with no cerebral protection in patients undergoing …
Cerebral embolic protection during transcatheter aortic valve replacement significantly reduces death and stroke compared with unprotected procedures
J Seeger, B Gonska, M Otto, W Rottbauer… - JACC: Cardiovascular …, 2017 - jacc.org
Objectives: The aim of this study was to evaluate the impact of cerebral embolic protection
on stroke-free survival in patients undergoing transcatheter aortic valve replacement …
on stroke-free survival in patients undergoing transcatheter aortic valve replacement …
Randomized evaluation of TriGuard 3 cerebral embolic protection after transcatheter aortic valve replacement: REFLECT II
TM Nazif, J Moses, R Sharma, A Dhoble, J Rovin… - Cardiovascular …, 2021 - jacc.org
Abstract Objectives The REFLECT II (Randomized Evaluation of TriGuard 3 Cerebral
Embolic Protection After Transcatheter Aortic Valve Implantation) trial was designed to …
Embolic Protection After Transcatheter Aortic Valve Implantation) trial was designed to …
A randomized evaluation of the TriGuard™ HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic …
Abstract Aims The REFLECT I trial investigated the safety and effectiveness of the
TriGuard™ HDH (TG) cerebral embolic deflection device in patients undergoing …
TriGuard™ HDH (TG) cerebral embolic deflection device in patients undergoing …
Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events
Transcatheter aortic valve implantation (TAVI) has emerged as a therapeutic alternative for
patients with symptomatic aortic stenosis at high or prohibitive surgical risk. However …
patients with symptomatic aortic stenosis at high or prohibitive surgical risk. However …
Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: a patient-level propensity-matched analysis
J Seeger, SR Kapadia, S Kodali, A Linke… - European Heart …, 2019 - academic.oup.com
Aims The role of cerebral embolic protection (CEP) in transcatheter aortic valve replacement
(TAVR) remains controversial. Randomized trials have not been powered to demonstrate a …
(TAVR) remains controversial. Randomized trials have not been powered to demonstrate a …